Journal
/
Developmental Biology
/
A Patient-Derived Xenograft Model for Venous Malformation
JoVE Journal
Developmental Biology
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Developmental Biology
A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

English

Automatically Generated

5,132 Views

•

06:51 min

•

June 15, 2020

DOI:

10.3791/61501-v

DOI:
10.3791/61501-v

•

06:51 min
June 15, 2020

•

2 Views
, ,
1Division of Experimental Hematology and Cancer Biology,Cincinnati Children’s Hospital Medical Center, 2Department of Pediatrics,University of Cincinnati College of Medicine

Summary

Automatically generated

We present a detailed protocol to generate a murine xenograft model of venous malformation. This model is based on the subcutaneous injection of patient-derived endothelial cells containing hyper-activating TIE2 and/or PIK3CA gene mutations. Xenograft lesions closely recapitulate the histopathological features of VM patient tissue.

Explore More Videos

Patient-derived XenograftVenous MalformationPreclinical Therapeutic TestingEndothelial CellsVascular AnomaliesTrypsinizationCell SuspensionCentrifugationBMEMAnesthesiaInjectionCaliper MeasurementFormalin Fixation

Read Article

Cite this Article

Schrenk, S., Goines, J., Boscolo, E. A Patient-Derived Xenograft Model for Venous Malformation. J. Vis. Exp. (160), e61501, doi:10.3791/61501 (2020).

Download .ris file

Copy

Share Video

.

Copy